Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Hahn

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Microorganisms|June 4, 2020
Mass Spectrometry-Based Characterization of the Virion Proteome, Phosphoproteome, and Associated Kinase Activity of Human CytomegalovirusYohann Couté, Alexandra Kraut, Christine Zimmermann, et al.
Antiviral Research|April 7, 2020
The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent miceMarkus Wild, Luca D Bertzbach, Pierre Tannig, et al.
ACS Medicinal Chemistry Letters|June 26, 2018
Synthesis of Thymoquinone-Artemisinin Hybrids: New Potent Antileukemia, Antiviral, and Antimalarial AgentsTony Fröhlich, Christoph Reiter, Mohamed E M Saeed, et al.
International Journal of Biological Macromolecules|June 4, 2019
Chemically sulfated polysaccharides from natural sources: Assessment of extraction-sulfation efficiencies, structural features and antiviral activitiesShuvam Mukherjee, Kanika Ghosh, Friedrich Hahn, et al.
Pathogens (Basel, Switzerland)|September 28, 2021
Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2Friedrich Hahn, Sigrun Häge, Alexandra Herrmann, et al.
Antiviral Research|April 18, 2025
The conserved core nuclear egress complex (NEC) as an antiherpesviral drug target: Pharmacophore-based identification of NEC-specific inhibitorsJulia Tillmanns, Verena Battisti, Jintawee Kicuntod, et al.
Chemmedchem|June 18, 2024
Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti-SARS-CoV-2 ActivityChristian Gege, Friedrich Hahn, Christina Wangen, et al.
Biochimica Et Biophysica Acta|December 11, 2012
Influenza A virus protein PB1-F2 from different strains shows distinct structural signaturesSara M Ø Solbak, Alok Sharma, Karsten Bruns, et al.
Bioorganic & Medicinal Chemistry|June 12, 2018
Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisininAysun Çapcı Karagöz, Christoph Reiter, Ean-Jeong Seo, et al.
ACS Medicinal Chemistry Letters|November 16, 2018
Synthesis of Artemisinin-Estrogen Hybrids Highly Active against HCMV, <i>P. falciparum</i>, and Cervical and Breast CancerTony Fröhlich, Anita Kiss, János Wölfling, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Microorganisms|June 4, 2020
Mass Spectrometry-Based Characterization of the Virion Proteome, Phosphoproteome, and Associated Kinase Activity of Human CytomegalovirusYohann Couté, Alexandra Kraut, Christine Zimmermann, et al.
Antiviral Research|April 7, 2020
The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent miceMarkus Wild, Luca D Bertzbach, Pierre Tannig, et al.
ACS Medicinal Chemistry Letters|June 26, 2018
Synthesis of Thymoquinone-Artemisinin Hybrids: New Potent Antileukemia, Antiviral, and Antimalarial AgentsTony Fröhlich, Christoph Reiter, Mohamed E M Saeed, et al.
International Journal of Biological Macromolecules|June 4, 2019
Chemically sulfated polysaccharides from natural sources: Assessment of extraction-sulfation efficiencies, structural features and antiviral activitiesShuvam Mukherjee, Kanika Ghosh, Friedrich Hahn, et al.
Pathogens (Basel, Switzerland)|September 28, 2021
Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2Friedrich Hahn, Sigrun Häge, Alexandra Herrmann, et al.
Antiviral Research|April 18, 2025
The conserved core nuclear egress complex (NEC) as an antiherpesviral drug target: Pharmacophore-based identification of NEC-specific inhibitorsJulia Tillmanns, Verena Battisti, Jintawee Kicuntod, et al.
Chemmedchem|June 18, 2024
Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti-SARS-CoV-2 ActivityChristian Gege, Friedrich Hahn, Christina Wangen, et al.
Biochimica Et Biophysica Acta|December 11, 2012
Influenza A virus protein PB1-F2 from different strains shows distinct structural signaturesSara M Ø Solbak, Alok Sharma, Karsten Bruns, et al.
Bioorganic & Medicinal Chemistry|June 12, 2018
Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisininAysun Çapcı Karagöz, Christoph Reiter, Ean-Jeong Seo, et al.
ACS Medicinal Chemistry Letters|November 16, 2018
Synthesis of Artemisinin-Estrogen Hybrids Highly Active against HCMV, <i>P. falciparum</i>, and Cervical and Breast CancerTony Fröhlich, Anita Kiss, János Wölfling, et al.
Pageof 6